Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRAGEM: Gemcitabine with or without Dalteparin in Pancreatic Cancer
NCT00462852Phase 2Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Apr 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dalteparin in venous thromboembolism (VTE), sponsored by Hull University Teaching Hospitals. Started Apr 2003; status: completed.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00462852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462852.